In 2022, the Population Council acquired the monthly dapivirine vaginal ring and other HIV prevention technologies from the International Partnership for Microbicides (IPM).
The acquisition expands our Center for Biomedical Research’s product portfolio, solidifying the Council’s position as the leading innovator of high quality sexual and reproductive health products that enhance choice for individuals in the global market.
IPM South Africa is a locally-registered affiliate of the Population Council with a separate board of trustees.